Skip to content

Biodentine Versus White MTA Pulpotomy

The Clinical and Radiographic Efficacy of Biodentine™ and White Mineral Trioxide Aggregate in Deciduous Molar Pulpotomy - a Randomized Control Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01733420
Enrollment
120
Registered
2012-11-27
Start date
2011-10-04
Completion date
2016-02-29
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extensive Decay in Primary Molars

Brief summary

A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth. Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.

Interventions

DRUGWhite MTA pulpotomy
DRUGTempophore pulpotomy

Sponsors

University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients (Children with carious deciduous molars indicated for pulpotomy) belonging to the category of ASA I according to the 'American Society of Anaesthesiologists'. * Patients without any known medical history of systemic complications contradicting pulp treatment. * Patients are indicated for treatment under general anaesthesia due to polycaries / fear / anxiety / very young age. * Written consent is obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Clinical successes after pulpotomy.at baseline visitclinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility.
Clinical success after pulpotomy.3 months after pulpotomy.clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility.
Radiographic successes after pulpotomy.at baseline visitRadiographic criteria: presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of periradicular radiolucency and no loss or break of lamina dura.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026